Oncotelic Therapeutics (OTLC) Non Operating Income (2019 - 2026)
Oncotelic Therapeutics (OTLC) posted Non Operating Income of $1.18 million for Q2 2026, up 328.5% from $276,418 a year earlier.
Powered by 
Analysis
Oncotelic Therapeutics (OTLC) Non Operating Income (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Non Operating Income at Oncotelic Therapeutics was $365.21 million; for FY2025, it was $363.76 million.
- In prior years, Oncotelic Therapeutics' Non Operating Income was -$1.2 million in FY2024, -$1.56 million in FY2023, $14.4 million in FY2022 and -$1.39 million in FY2021.
- Quarterly Non Operating Income has run from a low of -$818,644 in Q4 2022 to a high of $364.37 million in Q4 2025 over five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | -202.00 Mn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | - |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | - |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | - |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 1.63 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | -130.00 Mn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | - |
| 10 | Oncotelic Therapeutics | 5.77 Mn | 4.94 Mn | - | 1.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.18 Mn |
| Dec 31, 2025 | 364.37 Mn |
| Sep 30, 2025 | -623,396.00 |
| Jun 30, 2025 | 276,418.00 |
| Mar 31, 2025 | -263,164.00 |
| Dec 31, 2024 | -623,007.00 |
| Sep 30, 2024 | -90,894.00 |
| Jun 30, 2024 | -181,591.00 |
| Mar 31, 2024 | -307,953.00 |
| Dec 31, 2023 | -677,609.00 |
| Sep 30, 2023 | 26,583.00 |
| Jun 30, 2023 | -528,106.00 |
| Mar 31, 2023 | -341,928.00 |
| Dec 31, 2022 | -818,644.00 |
| Sep 30, 2022 | -263,997.00 |
| Jun 30, 2022 | 16.23 Mn |
| Mar 31, 2022 | -746,115.00 |
| Dec 31, 2021 | -456,279.00 |
| Sep 30, 2021 | -46,567.00 |
| Jun 30, 2021 | 196,195.00 |
API Access
Oncotelic Therapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=OTLC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "OTLC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=OTLC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();